H.R. 1672: Maintaining Investments in New Innovation Act

H.R. 1672 is a federal bill in the 119th Congress. Before this bill, the government could begin negotiating the prices of certain biological drugs after they had been on the market for 11 years. Under this bill, drugs developed using genetically targeted technology must be on the market for at least 11… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.